(Anna Marie Yanny, Wisconsin Public Radio) Neurosurgeon and professor Mahua Dey is concerned her team’s effort to develop a glioblastoma vaccine at the University of Wisconsin-Madison could stall as sweeping actions by the current administration to curb federal health funding trickle down to individual labs.
According to Anna Marie Yanny with the Wisconsin Public Radio, the goal of her research is to develop a personalized vaccine that could train glioblastoma patients’ immune systems to prevent their cancer from recurring.
Glioblastoma is a deadly form of brain cancer. For most, the disease is fatal in less than two years. “As a neurosurgeon, I treat patients with glioblastoma,” said Dey, an associate professor of neurosurgery and the director of the surgical neuro-oncology program at the UW School of Medicine and Public Health…